4 Matching Annotations
  1. Last 7 days
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
    2
    1. scibot 31 Jul 2024
      RRID:AB_2677389

      DOI: 10.1158/2159-8290.CD-23-0539

      Resource: (Atlas Antibodies Cat# HPA041275, RRID:AB_2677389)

      Curator: @scibot

      SciCrunch record: RRID:AB_2677389

      What is this?
      RRID:AB_2677389
    2. scibot 31 Jul 2024
      RRID:AB_2677389

      DOI: 10.1158/2159-8290.CD-23-0539

      Resource: (Atlas Antibodies Cat# HPA041275, RRID:AB_2677389)

      Curator: @scibot

      SciCrunch record: RRID:AB_2677389

      What is this?
      RRID:AB_2677389
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11285331/
  3. Nov 2023
  4. www.biorxiv.org www.biorxiv.org
    ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers
    1
    1. scibot 03 Nov 2023
      RRID:AB_2677389

      DOI: 10.1101/2023.10.24.563645

      Resource: (Atlas Antibodies Cat# HPA041275, RRID:AB_2677389)

      Curator: @scibot

      SciCrunch record: RRID:AB_2677389

      What is this?
      RRID:AB_2677389
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.10.24.563645v1
  5. Jul 2023
  6. www.sciencedirect.com www.sciencedirect.com
    Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
    1
    1. scibot 21 Jul 2023
      RRID:AB_2677389

      DOI: 10.1016/j.ccell.2023.06.010

      Resource: (Atlas Antibodies Cat# HPA041275, RRID:AB_2677389)

      Curator: @scibot

      SciCrunch record: RRID:AB_2677389

      What is this?
      RRID:AB_2677389
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610823002350